📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences. (2023)

First Author: Kitonsa J

Attributed to: Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21645515.2023.2240690

PubMed Identifier: 37553178

Publication URI: http://europepmc.org/abstract/MED/37553178

Type: Journal Article/Review

Volume: 19

Parent Publication: Human vaccines & immunotherapeutics

Issue: 2

ISSN: 2164-5515